Genetic approaches to understanding the pathophysiology of complex human traits (Q40496273)

21 September 2017

1 reference

title

Genetic approaches to understanding the pathophysiology of complex human traits (English)

1 reference

21 September 2017

Williams GH

1

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

21 September 2017

1 reference

21 September 2017

volume

46

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

1550-1553

1 reference

The investigation of linkage between a quantitative trait and a marker locus

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Robust methods for the detection of genetic linkage for quantitative data from pedigrees

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Exclusion of the Na(+)-H+ antiporter as a candidate gene in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Sibling Method for Detecting HLA-linked genes in disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

A comparison of sib-pair linkage tests for disease susceptibility loci

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

A test statistic for the affected-sib-set method

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

A comparison of three affected-sib-pair scoring methods to detect HLA-linked disease susceptibility genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Molecular basis of human hypertension: role of angiotensinogen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Renal and endocrine response to saline infusion in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Evidence for heritability of non-modulating essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Non-modulation as an intermediate phenotype in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.443

7 January 2021

Identifiers

DOI

10.1038/KI.1994.443

1 reference

Dimensions Publication ID

21 September 2017

1050716700

0 references

1 reference